| [1] |
Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia: part 1(中华人民共和国药典:一部) [S]. Beijing: China Medical Science Press, 2020.
|
| [2] |
Yang LX, Zhang YY, Wang FF, et al. Toxicity of mercury: Molecular evidence. Chemosphere[J]. 2020, 245: 125586.
|
| [3] |
Zhao MJ. Analysis of clinical characteristics and risk factors of adverse reactions induced by Chinese herbal pieces for tranquilization[J]. Clin Res Pract (临床医学研究与实践), 2020, 5(21): 24-26.
|
| [4] |
Chen XX. Analysis of reasons for adverse reactions of sedative Chinese medicine decoction pieces and the countermeasures for rational use of drugs[J]. Clin Res Pract (临床医学研究与实践), 2018, 3(35): 139-140.
|
| [5] |
Pan Y. Analysis on the reasonable application and clinical safety of cinnabar[J]. Chin Med Mod Distance Educ China (中国中医药现代远程教育), 2018, 16(14): 56-58.
|
| [6] |
Lohren H, Blagojevic L, Fitkau R, et al. Toxicity of organic and inorganic mercury species in differentiated human neurons and human astrocytes[J]. J Trace Elem Med Biol, 2015, 32: 200-208.
|
| [7] |
Sulaiman R, Wang M, Ren X. Exposure to aluminum, cadmium, and mercury and autism spectrum disorder in children: a systematic review and Meta-analysis[J]. Chem Res Toxicol, 2020, 33(11): 2699-2718.
|
| [8] |
Ganguly J, Kulshreshtha D, Jog M. Mercury and movement disorders: the toxic legacy continues[J]. Can J Neurol Sci, 2022, 49(4): 493-501.
|
| [9] |
Weihe P, Debes F, White RF, et al. Environmental epidemiology research leads to a decrease of the exposure limit for mercury[J]. Ugeskr Laeger, 2003, 165(2): 107-111.
|
| [10] |
Lu YT, Qi WZ, Wang S, et al. Toxicity and risk assessment of mercury exposures from cinnabar and Baizi Yangxin Pills based on pharmacokinetic and tissue distribution studies[J]. J Ethnopharmacol, 2020, 250: 112489.
|
| [11] |
Joo H, Lim MH, Ha M, et al. Secondhand smoke exposure and low blood lead levels in association with attention-deficit hyperactivity disorder and its symptom domain in children: a community-based case-control study[J]. Nicotine Tob Res, 2017, 19(1): 94-101.
|
| [12] |
Liu BH, Yang MM, Ma NN, et al. Pharmacokinetics of mercury after oral single-dose of cinnabar and cinnabar-containing pediatric medication ''Yinianjin''in blood of juvenile rats[J]. J Toxicol (毒理学杂志), 2018, 32(1): 7-10.
|
| [13] |
Liu BH, Li LD, Xie Q, et al. Neurobehavioral effects of cinnabar and the cinnabar-containing pediatric prescription, Yi-Nian-Jin, in juvenile rats[J]. J Trace Elem Med Biol, 2023, 76: 127112.
|
| [14] |
U. S. Food and Drug Administration. Import Alert 66-10[R]. Washington D. C. :FDA,2011.
|
| [15] |
Medicines and Healthcare products Regulatory Agency. Arsenic and Mercury in Ayurvedic and Traditional Chinese Medicines[R]. London: MRHA, 2005.
|
| [16] |
Lu YT, Yang DY, Song XN, et al. Bioaccessibility and health risk assessment of mercury in cinnabar containing Traditional Chinese Medicines[J]. J Trace Elem Med Biol, 2017, 44: 17-25.
|
| [17] |
Arain AL, Neitzel RL. A review of biomarkers used for assessing human exposure to metals from E-waste[J]. Int J Environ Res Public Health, 2019, 16(10): 1802.
|
下载:
